辛伐他汀联合丹参治疗不稳定型心绞痛的疗效观察(2)
![]() |
第1页 |
参见附件。
参考文献
[1]Spencer FA,Allegrone J,Goldberg RJ,et al.Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study[J].Ann Intern Med,2004,140(11):857-866.
[2]许爱莲.单硝酸异山梨酯联合低分子肝素治疗不稳定型心绞痛42例观察[J].右江医学,2011,39(6):745-747.
[3]江 洪.低分子肝素联合辛伐他汀治疗不稳定型心绞痛疗效观察[J].右江医学,2008,36(4):396-397.
[4]Chia S, Senatore F,Raffel OC,et al.Utility of cardiac biomarkers in predicting infarct size,left ventricular function,and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].JACC Cardiovasc Interv,2008,1(4):415-423.
[5]Park JW,Lee SH,Yang MK,et al.15,16-dihydrotanshinone I, a major component from Salvia miltiorrhiza Bunge (Dansham), inhibits rabbit platelet aggregation by suppressing intracellular calcium mobilization[J].Arch Pharm Res,2008,31(1):47-53.
[6]Li MH, Chen JM, Peng Y, et al.Investigation of Danshen and related medicinal plants in China[J].J Ethnopharmacol, 2008,120(3):419-426.
(收稿日期:2012-06-24 修回日期:2012-07-18)
(编辑:梁明佩)
您现在查看是摘要介绍页,详见PDF附件(3351kb)。